Kingsview Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Sell |
499
-46
| -8% | -$20.5K | ﹤0.01% | 1065 |
|
|
2025
Q1 | $264K | Buy |
+545
| New | +$264K | 0.01% | 937 |
|
|
2024
Q4 | – | Sell |
-447
| Closed | -$208K | – | 1192 |
|
|
2024
Q3 | $208K | Buy |
+447
| New | +$208K | ﹤0.01% | 1028 |
|
|
2023
Q1 | – | Sell |
-1,376
| Closed | -$397K | – | 950 |
|
|
2022
Q4 | $397K | Buy |
+1,376
| New | +$397K | 0.02% | 580 |
|
|
2022
Q3 | – | Sell |
-2,499
| Closed | -$704K | – | 886 |
|
|
2022
Q2 | $704K | Sell |
2,499
-139
| -5% | -$39.2K | 0.03% | 456 |
|
|
2022
Q1 | $688K | Sell |
2,638
-99
| -4% | -$25.8K | 0.03% | 504 |
|
|
2021
Q4 | $601K | Sell |
2,737
-140
| -5% | -$30.7K | 0.03% | 520 |
|
|
2021
Q3 | $522K | Sell |
2,877
-35
| -1% | -$6.35K | 0.02% | 532 |
|
|
2021
Q2 | $589K | Buy |
2,912
+78
| +3% | +$15.8K | 0.03% | 516 |
|
|
2021
Q1 | $604K | Sell |
2,834
-881
| -24% | -$188K | 0.03% | 467 |
|
|
2020
Q4 | $878K | Buy |
3,715
+1,281
| +53% | +$303K | 0.06% | 308 |
|
|
2020
Q3 | $662K | Buy |
+2,434
| New | +$662K | 0.06% | 307 |
|